WhiteLab Genomics
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
$26MSeries B
ParticipantActivity from announced rounds
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
Develops multi-state fusion technology for medical radioisotopes and commercial applications
Develops wholesale space infrastructure for telecom operators to provide high-speed internet access
Pitching Blast Club? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room